[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Asia-Pacific Meningioma Drug Market Analysis 2012-2017 and Forecast 2018-2023

May 2018 | 155 pages | ID: A9D9F407AB2EN
99Strategy

US$ 3,300.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Snapshot

The Asia-Pacific Meningioma Drug market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Meningioma Drug by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
  • Abemaciclib
  • Afatinib Dimaleate
  • AR-42
  • Avelumab
  • Others
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
  • Arno Therapeutics Inc
  • AstraZeneca Plc
  • Boehringer Ingelheim GmbH
  • Eli Lilly and Co
  • Genentech Inc
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • Merck KGaA
  • Novartis AG
  • Ono Pharmaceutical Co Ltd
  • Pharma Mar SA
  • Progenics Pharmaceuticals Inc
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
  • Hospital
  • Clinic
  • Others
Region Coverage (Regional Production, Demand & Forecast by Regions etc.):
  • China
  • Japan & Korea
  • India
  • Southeast Asia
  • Oceania
1 INDUSTRY OVERVIEW

1.1 Meningioma Drug Industry
  1.1.1 Overview
  1.1.2 Development of Meningioma Drug
1.2 Market Segment
  1.2.1 By Product Type
  1.2.2 By Application
1.3 Asia-Pacific Overview

2 MAJOR COMPANIES LIST

2.1 Arno Therapeutics Inc (Company Profile, Products & Services, Sales Data etc.)
2.2 AstraZeneca Plc (Company Profile, Products & Services, Sales Data etc.)
2.3 Boehringer Ingelheim GmbH (Company Profile, Products & Services, Sales Data etc.)
2.4 Eli Lilly and Co (Company Profile, Products & Services, Sales Data etc.)
2.5 Genentech Inc (Company Profile, Products & Services, Sales Data etc.)
2.6 GlaxoSmithKline Plc (Company Profile, Products & Services, Sales Data etc.)
2.7 Merck & Co Inc (Company Profile, Products & Services, Sales Data etc.)
2.8 Merck KGaA (Company Profile, Products & Services, Sales Data etc.)
2.9 Novartis AG (Company Profile, Products & Services, Sales Data etc.)
2.10 Ono Pharmaceutical Co Ltd (Company Profile, Products & Services, Sales Data etc.)
2.11 Pharma Mar SA (Company Profile, Products & Services, Sales Data etc.)
2.12 Progenics Pharmaceuticals Inc (Company Profile, Products & Services, Sales Data etc.)

3 MARKET COMPETITION

3.1 Company Competition
3.2 Regional Market by Company

4 MENINGIOMA DRUG MARKET BY TYPE

4.1 By Type
  4.1.1 Abemaciclib
  4.1.2 Afatinib Dimaleate
  4.1.3 AR-42
  4.1.4 Avelumab
  4.1.5 Others
4.2 Market Size
4.3 Market Forecast

5 MARKET DEMAND

5.1 Demand Situation
  5.1.1 Demand in Hospital
  5.1.2 Demand in Clinic
  5.1.3 Demand in Others
5.2 Regional Demand Comparison
5.3 Demand Forecast

6 REGION OPERATION

6.1 Regional Production
6.2 Regional Market
6.3 by Region
  6.3.1 China
    6.3.1.1 By Type
    6.3.1.2 By Application
  6.3.2 Japan & Korea
    6.3.2.1 By Type
    6.3.2.2 By Application
  6.3.3 India
    6.3.3.1 By Type
    6.3.3.2 By Application
  6.3.4 Southeast Asia
    6.3.4.1 By Type
    6.3.4.2 By Application
  6.3.5 Oceania
    6.3.5.1 By Type
    6.3.5.2 By Application
6.4 Regional Forecast

7 MARKETING & PRICE

7.1 Price and Margin
  7.1.1 Price Trends
  7.1.2 Factors of Price Change
  7.1.3 Manufacturers Gross Margin Analysis
7.2 Marketing Channel

8 UPSTREAM & COST

8.1 Upstream
8.2 Cost

9 INDUSTRY ENVIRONMENT

9.1 Policy
9.2 Economics
9.3 Sociology
9.4 Technology

10 RESEARCH CONCLUSION-LIST OF TABLES

Table PRODUCT SEGMENT OF MENINGIOMA DRUG
Table Asia-Pacific Meningioma Drug Market 2012-2023, by Product Type, in USD Million
Table Application Segment of Meningioma Drug
Table Asia-Pacific Meningioma Drug Market 2012-2023, by Application, in USD Million
Table Arno Therapeutics Inc Overview List
Table Meningioma Drug Business Operation of Arno Therapeutics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Plc Overview List
Table Meningioma Drug Business Operation of AstraZeneca Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim GmbH Overview List
Table Meningioma Drug Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly and Co Overview List
Table Meningioma Drug Business Operation of Eli Lilly and Co (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Genentech Inc Overview List
Table Meningioma Drug Business Operation of Genentech Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Plc Overview List
Table Meningioma Drug Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co Inc Overview List
Table Meningioma Drug Business Operation of Merck & Co Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck KGaA Overview List
Table Meningioma Drug Business Operation of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis AG Overview List
Table Meningioma Drug Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ono Pharmaceutical Co Ltd Overview List
Table Meningioma Drug Business Operation of Ono Pharmaceutical Co Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pharma Mar SA Overview List
Table Meningioma Drug Business Operation of Pharma Mar SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Progenics Pharmaceuticals Inc Overview List
Table Meningioma Drug Business Operation of Progenics Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Asia-Pacific Meningioma Drug Sales Revenue 2012-2017, by Company, in USD Million
Table Asia-Pacific Meningioma Drug Sales Revenue Share, by Company, in USD Million
Table Asia-Pacific Meningioma Drug Sales Volume 2012-2017, by Company, in Volume
Table Asia-Pacific Meningioma Drug Sales Volume Share 2012-2017, by Company, in Volume
Table Major Company List of Abemaciclib
Table Major Company List of Afatinib Dimaleate
Table Major Company List of AR-42
Table Major Company List of Avelumab
Table Major Company List of Others
Table Asia-Pacific Meningioma Drug Market 2012-2017, by Type, in USD Million
Table Asia-Pacific Meningioma Drug Market 2012-2017, by Type, in Volume
Table Asia-Pacific Meningioma Drug Market Forecast 2018-2023, by Type, in USD Million
Table Asia-Pacific Meningioma Drug Market Forecast 2018-2023, by Type, in Volume
Table Meningioma Drug Demand in Hospital, 2012-2017, in USD Million
Table Meningioma Drug Demand in Hospital, 2012-2017, in Volume
Table Major Consumers in Hospital
Table Meningioma Drug Demand in Clinic, 2012-2017, in USD Million
Table Meningioma Drug Demand in Clinic, 2012-2017, in Volume
Table Major Consumers in Clinic
Table Meningioma Drug Demand in Others, 2012-2017, in USD Million
Table Meningioma Drug Demand in Others, 2012-2017, in Volume
Table Major Consumers in Others
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Meningioma Drug Demand Forecast 2018-2023, by Application, in USD Million
Table Meningioma Drug Demand Forecast 2018-2023, by Application, in Volume
Table Meningioma Drug Production 2012-2017, by Region, in USD Million
Table Meningioma Drug Production 2012-2017, by Region, in Volume
Table Asia-Pacific Meningioma Drug Market Size 2012-2017, by Region, in USD Million
Table Asia-Pacific Meningioma Drug Market Size 2012-2017, by Region, in Volume
Table China Meningioma Drug Market Size 2012-2017, by Type, in USD Million
Table China Meningioma Drug Market Size 2012-2017, by Type, in Volume
Table China Meningioma Drug Market Size 2012-2017, by Application, in USD Million
Table China Meningioma Drug Market Size 2012-2017, by Application, in Volume
Table Japan & Korea Meningioma Drug Market Size 2012-2017, by Country, in USD Million
Table Japan & Korea Meningioma Drug Market Size 2012-2017, by Country, in Volume
Table Japan Meningioma Drug Market Size 2012-2017, by Type, in USD Million
Table Japan Meningioma Drug Market Size 2012-2017, by Type, in Volume
Table Japan Meningioma Drug Market Size 2012-2017, by Application, in USD Million
Table Japan Meningioma Drug Market Size 2012-2017, by Application, in Volume
Table India Meningioma Drug Market Size 2012-2017, by Country, in USD Million
Table India Meningioma Drug Market Size 2012-2017, by Country, in Volume
Table India Meningioma Drug Market Size 2012-2017, by Type, in USD Million
Table India Meningioma Drug Market Size 2012-2017, by Type, in Volume
Table India Meningioma Drug Market Size 2012-2017, by Application, in USD Million
Table India Meningioma Drug Market Size 2012-2017, by Application, in Volume
Table Southeast Asia Meningioma Drug Market Size 2012-2017, by Country, in USD Million
Table Southeast Asia Meningioma Drug Market Size 2012-2017, by Country, in Volume
Table Southeast Asia Meningioma Drug Market Size 2012-2017, by Type, in USD Million
Table Southeast Asia Meningioma Drug Market Size 2012-2017, by Type, in Volume
Table Southeast Asia Meningioma Drug Market Size 2012-2017, by Application, in USD Million
Table Southeast Asia Meningioma Drug Market Size 2012-2017, by Application, in Volume
Table Oceania Meningioma Drug Market Size 2012-2017, by Country, in USD Million
Table Oceania Meningioma Drug Market Size 2012-2017, by Country, in Volume
Table Oceania Meningioma Drug Market Size 2012-2017, by Type, in USD Million
Table Oceania Meningioma Drug Market Size 2012-2017, by Type, in Volume
Table Oceania Meningioma Drug Market Size 2012-2017, by Application, in USD Million
Table Oceania Meningioma Drug Market Size 2012-2017, by Application, in Volume
Table Meningioma Drug Market Forecast 2018-2023, by Region, in USD Million
Table Meningioma Drug Market Forecast 2018-2023, by Region, in Volume
Table Price Factors List
Table Upstream Segment of Meningioma Drug

LIST OF FIGURES

Figure Meningioma Drug Industry Chain Structure
Figure Asia-Pacific Meningioma Drug Market Size and Growth Rate 2012-2023
Figure China Meningioma Drug Market, by Company, in 2018
Figure Japan & Korea Meningioma Drug Market, by Company, in 2018
Figure India Meningioma Drug Market, by Company, in 2018
Figure Southeast Asia Meningioma Drug Market, by Company, in 2018
Figure Oceania Meningioma Drug Market, by Company, in 2018
Figure Asia-Pacific Meningioma Drug Market Growth 2012-2017, by Type, in USD Million
Figure Asia-Pacific Meningioma Drug Market Growth 2012-2017, by Type, in Volume
Figure China Meningioma Drug Market Size and Growth 2012-2017, in USD Million
Figure China Meningioma Drug Market Size and Growth 2012-2017, in Volume
Figure Japan & Korea Meningioma Drug Market Size and Growth 2012-2017, in USD Million
Figure Japan & Korea Meningioma Drug Market Size and Growth 2012-2017, in Volume
Figure India Meningioma Drug Market Size and Growth 2012-2017, in USD Million
Figure India Meningioma Drug Market Size and Growth 2012-2017, in Volume
Figure Southeast Asia Meningioma Drug Market Size and Growth 2012-2017, in USD Million
Figure Southeast Asia Meningioma Drug Market Size and Growth 2012-2017, in Volume
Figure Oceania Meningioma Drug Market Size and Growth 2012-2017, in USD Million
Figure Oceania Meningioma Drug Market Size and Growth 2012-2017, in Volume
Figure Marketing Channels Overview


More Publications